
Biology, Journal Year: 2025, Volume and Issue: 14(3), P. 275 - 275
Published: March 7, 2025
Diabetic retinopathy (DR) is a major complication of diabetes, leading to vision impairment and blindness. The pathogenesis DR involves multiple factors, including hyperglycemia-induced vascular damage, hypertension, obesity, anemia, immune dysregulation, disruption the blood–retinal barrier (BRB). Th17 Treg cells, two types CD4+ T play opposing roles in inflammation. cells are pro-inflammatory, producing cytokines such as IL-17A, while help suppress responses promote anti-inflammatory effects. Recent studies highlight importance Th17/Treg balance retinal inflammation disease progression DR. Our literature review reveals an imbalance DR, with increased activity reduced function. This shift creates pro-inflammatory environment retina, worsening leakage, neovascularization, loss. limited infiltration suggests that may uniquely infiltrate retina by overwhelming or outnumbering Tregs increasing expression recruiting chemokines, rather than only taking advantage damaged BRB. Therapeutic strategies, neutralizing IL-17A enhancing function compounds like IL-35 curcumin, reduce damage. Restoring between could provide new approaches for treating controlling preventing further
Language: Английский